key: cord-0252653-wrzdnv2f
authors: Joob, B.; Wiwanitkit, V.
title: COVID-19 and Organ Transplantation
date: 2020
journal: Int J Organ Transplant Med
DOI: nan
sha: f38681e263051f2d435cd67a2762434cd1ee482d
doc_id: 252653
cord_uid: wrzdnv2f

nan

C OVID-19 is an emerging viral infection. It originated from China; it then progressed to Thailand and other countries including Iran [1, 2] . Thousands of cases have been reported worldwide. There are many patients with underlying medical risks. Herein, we would like to focus on those factors relevant to transplantation medicine. So far, there is no official report of infection in patients who underwent organ transplantation. In MERS, another emerging coronavirus infection, organ transplant recipients could be infected, but rarely [3] .

The infection is still in its first few months, and it mainly affects travelers. Therefore, the chance for organ transplant recipients is very low. However, in a pandemic, the infection might also affect organ transplant recipients. Another hypothesis would be the potential protective effect of immunosuppressive drugs and prophylactic chemotherapy used by organ transplant recipients against the disease.

None declared.

Emerging new coronavirus infection in Wuhan, China: Situation in early 2020

Editorial: Wuhan coronavirus outbreak and imported case

MERS CoV infection in two renal transplant recipients: case report